Mali Khan supports clients with research and analysis that span a variety of healthcare sectors and stakeholders.

She applies her background in health policy and healthcare management to a broad range of client projects.

Prior to joining Avalere, Mali held a variety of internship positions, including an internship with PATH where she performed literature reviews and managed project coordination of global nutrition policies and plans to support efforts to improve international health. Additionally, she supported the Gillings School of Global Public Health where she collaborated with the Department of Nutrition to enhance research centered on child feeding practices in Tanzania and reviewed, coded, and analyzed data for the research team.

Mali has a BS in public health from the University of North Carolina at Chapel Hill.

Authored Content


Tune into another episode of Avalere’s Journal Club Review podcast series on Avalere Health Essential Voice. In this segment, Dr. Sura Edmond, a Research Scientist in the Center for Healthcare Transformation, joins Associate Mali Khan to discuss the findings, themes, and relevant application of a contemporary healthcare publication.

On July 22, Avalere experts discussed the marketplace for COVID-19 vaccines and therapeutics in the “Cutting Through the Noise: Market Evolution and Pathways to Access for COVID-19 Vaccines and Therapeutics” webinar. They examined FDA regulatory considerations, coverage and access challenges, and key pricing and distribution scenarios for optimal US market access.

Avalere is releasing a new research agenda to guide evidence generation for health system models of care that advance the intersection of social and clinical needs of Medicaid-eligible individuals.

On June 11, Avalere experts explored the future of telehealth and how organizations can help shape and take advantage of its increased utilization.

On June 9, Avalere experts discussed new data analytics and approaches for evaluating value-based topics in healthcare in the “New Data Approaches for Novel Curative Therapies & APMs” webinar. They examined the current approaches to assessing the value of treatments, novel curative therapy affordability and access, and the role of data in healthcare decision-making.